Skip to content
Search

Latest Stories

Alliance Healthcare pledges to achieve net zero carbon footprint by 2030

Alliance Healthcare, the UK’s largest pharmaceutical wholesaler, has pledged to support the global efforts to cut carbon emissions, as set out at the recent UN Climate Change Conference, COP26.

The company’s pledge is in line with its aim to create “healthier futures and the business”, on which it has been working on for years.


It aims to become the most sustainable independent full-line pharmaceutical wholesaler in the UK by 2030, ensuring to remain the sustainable partner of choice for its customers and manufacturers.

Alliance Healthcare UK driver stacking totes outside van 2 Alliance Healthcare UK driver stacking totes outside van

To achieve the target, Alliance Healthcare has listed some steps, such as reduction in use of single-use plastic in the UK business by 60 per cent by September 2022, switch from plastic bubble wrap to a paper alternative, ensure responsible sourcing of materials, water and energy conservation.

Julian Mount, managing director, Alliance Healthcare UK said, it is “vital that we make this pledge and work hard to meet the commitments and targets we have set to achieve by 2030.

“I firmly believe that by working in partnership with industry partners and supporting their commitments as well as our own ensures we are all on the same path in our mission to tackle climate change.”

He added that it is everyone’s duty to tackle climate change and “strive to meet the global targets.”

Mount said: “Today everyone at Alliance Healthcare is encouraged to make a personal sustainability pledge on our internal pledge trees, as we all continue to play a personal role in this commitment.”

Earlier this year, Alliance Healthcare’s parent company - AmerisourceBergen committed to Science-Based Targets (SBTs) and announced an interim target which the Alliance Healthcare UK business will be supporting.

SBTs provide a clearly-defined pathway for companies to reduce greenhouse gas emissions, helping prevent the worst impacts of climate change and future-proof business growth.

Gina Clark, executive vice president and chief communications & administration officer for AmerisourceBergen, said: “We are committed to fostering a positive impact on people and planet through the work we do and the communities we serve”.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less